Rotavirus Interactions With Host Intestinal Epithelial Cells

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Jan 10

PMID 35003114

Authors

Joshua Oluoch Amimo

Sergei Alekseevich Raev

Juliet Chepngeno

Alfred Omwando Mainga

Yusheng Guo

Linda Saif

Anastasia N Vlasova

Affiliations

Soon will be listed here.

Abstract

Rotavirus (RV) is the foremost enteric pathogen associated with severe diarrheal illness in young children (<5years) and animals worldwide. RV primarily infects mature enterocytes in the intestinal epithelium causing villus atrophy, enhanced epithelial cell turnover and apoptosis. Intestinal epithelial cells (IECs) being the first physical barrier against RV infection employs a range of innate immune strategies to counteract RVs invasion, including mucus production, toll-like receptor signaling and cytokine/chemokine production. Conversely, RVs have evolved numerous mechanisms to escape/subvert host immunity, seizing translation machinery of the host for effective replication and transmission. RV cell entry process involve penetration through the outer mucus layer, interaction with cell surface molecules and intestinal microbiota before reaching the IECs. For successful cell attachment and entry, RVs use sialic acid, histo-blood group antigens, heat shock cognate protein 70 and cell-surface integrins as attachment factors and/or (co)-receptors. In this review, a comprehensive summary of the existing knowledge of mechanisms underlying RV-IECs interactions, including the role of gut microbiota, during RV infection is presented. Understanding these mechanisms is imperative for developing efficacious strategies to control RV infections, including development of antiviral therapies and vaccines that target specific immune system antagonists within IECs.

Citing Articles

Regulation of Isoleucine on Colonic Barrier Function in Rotavirus-Infected Weanling Piglets and Analysis of Gut Microbiota and Metabolomics.

Jiang C, Chen W, Yang Y, Li X, Jin M, Ghonaim A Microorganisms. 2025; 12(12.

PMID: 39770598 PMC: 11676416. DOI: 10.3390/microorganisms12122396.

Loss of mucin 2 and MHC II molecules causes rare resistance to murine RV infection.

Bomidi C, Sawyer F, Sawyer F, Shroyer N, Conner M, Estes M J Virol. 2024; 99(2):e0150724.

PMID: 39727412 PMC: 11852729. DOI: 10.1128/jvi.01507-24.

Precursor of H-type II histo-blood group antigen and subterminal sialic acids on gangliosides are significantly implicated in cell entry and infection by a porcine P[11] rotavirus.

Yan M, Su A, Meyer D, Sosa G, Fritsch H, Pitters M Emerg Microbes Infect. 2024; 14(1):2447608.

PMID: 39726161 PMC: 11727068. DOI: 10.1080/22221751.2024.2447608.

tRNA-Ser-UGA efficiently promotes the rapid release of duck hepatitis A virus from infected enterocytes and its remote dissemination to hepatocytes.

Ou X, Gou Y, Gong L, Lin X, Liu Y, Yang W Poult Sci. 2024; 104(2):104655.

PMID: 39708671 PMC: 11729666. DOI: 10.1016/j.psj.2024.104655.

Development of RT-dPCR method and reference material for rotavirus G3P8 and G9P8.

Yang J, Liu M, Li H, Gao Y, Dong L Anal Bioanal Chem. 2024; .

PMID: 39676135 DOI: 10.1007/s00216-024-05690-2.

References

Xie P . TRAF molecules in cell signaling and in human diseases. J Mol Signal. 2013; 8(1):7. PMC: 3697994. DOI: 10.1186/1750-2187-8-7. View

Morales-Soto W, Gulbransen B . A novel mechanism of rotavirus infection involving purinergic signaling. Purinergic Signal. 2021; 17(2):169-171. PMC: 7891116. DOI: 10.1007/s11302-021-09773-y. View

Sanchez-Tacuba L, Rojas M, Arias C, Lopez S . Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms. J Virol. 2015; 89(23):12145-53. PMC: 4645303. DOI: 10.1128/JVI.01874-15. View

Arnold M, Patton J . Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains. J Virol. 2010; 85(5):1970-9. PMC: 3067804. DOI: 10.1128/JVI.01801-10. View

Lundgren O, Svensson L . Pathogenesis of rotavirus diarrhea. Microbes Infect. 2001; 3(13):1145-56. PMC: 7128947. DOI: 10.1016/s1286-4579(01)01475-7. View

Mackow E, Shaw R, Matsui S, Vo P, Benfield D, Greenberg H . Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology. 1988; 165(2):511-7. DOI: 10.1016/0042-6822(88)90595-8. View

Lin B, Dutta B, Fraser I . Systematic Investigation of Multi-TLR Sensing Identifies Regulators of Sustained Gene Activation in Macrophages. Cell Syst. 2017; 5(1):25-37.e3. PMC: 5584636. DOI: 10.1016/j.cels.2017.06.014. View

Kawai T, Akira S . [Role of IPS-1 in type I IFN induction]. Nihon Rinsho. 2006; 64(7):1231-5. View

Dimitrov D . Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol. 2004; 2(2):109-22. PMC: 7097642. DOI: 10.1038/nrmicro817. View

10.

Hu L, Crawford S, Czako R, Cortes-Penfield N, Smith D, Le Pendu J . Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature. 2012; 485(7397):256-9. PMC: 3350622. DOI: 10.1038/nature10996. View

11.

Banda K, Kang G, Varki A . 'Sialidase sensitivity' of rotaviruses revisited. Nat Chem Biol. 2009; 5(2):71-2. DOI: 10.1038/nchembio0209-71. View

12.

Bansil R, Turner B . The biology of mucus: Composition, synthesis and organization. Adv Drug Deliv Rev. 2017; 124:3-15. DOI: 10.1016/j.addr.2017.09.023. View

13.

Colina R, Costa-Mattioli M, Dowling R, Jaramillo M, Tai L, Breitbach C . Translational control of the innate immune response through IRF-7. Nature. 2008; 452(7185):323-8. DOI: 10.1038/nature06730. View

14.

Brockhausen I, Dowler T, Paulsen H . Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2. Biochim Biophys Acta. 2009; 1790(10):1244-57. DOI: 10.1016/j.bbagen.2009.05.020. View

15.

Sen A, Feng N, Ettayebi K, Hardy M, Greenberg H . IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation. J Virol. 2009; 83(20):10322-35. PMC: 2753142. DOI: 10.1128/JVI.01186-09. View

16.

Bagchi P, Bhowmick R, Nandi S, Nayak M, Chawla-Sarkar M . Rotavirus NSP1 inhibits interferon induced non-canonical NFκB activation by interacting with TNF receptor associated factor 2. Virology. 2013; 444(1-2):41-4. DOI: 10.1016/j.virol.2013.07.003. View

17.

Ishizuka T, Kanmani P, Kobayashi H, Miyazaki A, Soma J, Suda Y . Immunobiotic Bifidobacteria Strains Modulate Rotavirus Immune Response in Porcine Intestinal Epitheliocytes via Pattern Recognition Receptor Signaling. PLoS One. 2016; 11(3):e0152416. PMC: 4811565. DOI: 10.1371/journal.pone.0152416. View

18.

Guerrero C, Moreno L . Rotavirus receptor proteins Hsc70 and integrin αvβ3 are located in the lipid microdomains of animal intestinal cells. Acta Virol. 2012; 56(1):63-70. DOI: 10.4149/av_2012_01_63. View

19.

Jolly C, Beisner B, HOLMES I . Rotavirus infection of MA104 cells is inhibited by Ricinus lectin and separately expressed single binding domains. Virology. 2000; 275(1):89-97. DOI: 10.1006/viro.2000.0470. View

20.

Koyama S, Ishii K, Coban C, Akira S . Innate immune response to viral infection. Cytokine. 2008; 43(3):336-41. DOI: 10.1016/j.cyto.2008.07.009. View